512 related articles for article (PubMed ID: 28049687)
1. Towards a CRISPR view of early human development: applications, limitations and ethical concerns of genome editing in human embryos.
Plaza Reyes A; Lanner F
Development; 2017 Jan; 144(1):3-7. PubMed ID: 28049687
[TBL] [Abstract][Full Text] [Related]
2. Gene editing in human development: ethical concerns and practical applications.
Rossant J
Development; 2018 Jul; 145(16):. PubMed ID: 30045910
[TBL] [Abstract][Full Text] [Related]
3. [CRISPR-Cas9, germinal cells and human embryo].
Jouannet P
Biol Aujourdhui; 2017; 211(3):207-213. PubMed ID: 29412130
[TBL] [Abstract][Full Text] [Related]
4. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
5. [Genome editing in human embryos: ethical concerns and practical applications].
Akutsu H
Rinsho Ketsueki; 2019; 60(9):1033-1045. PubMed ID: 31597825
[TBL] [Abstract][Full Text] [Related]
6. [A new milestone in human embryo editing].
Jordan B
Med Sci (Paris); 2017 May; 33(5):549-554. PubMed ID: 28612733
[TBL] [Abstract][Full Text] [Related]
7. The Wisdom of Germline Editing: An Ethical Analysis of the Use of CRISPR-Cas9 to Edit Human Embryos.
Gumer JM
New Bioeth; 2019 Jun; 25(2):137-152. PubMed ID: 31130112
[TBL] [Abstract][Full Text] [Related]
8. The ethics of creating genetically modified children using genome editing.
Ishii T
Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):418-423. PubMed ID: 28885275
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9 technology: applications in oocytes and early embryos.
Zhang YR; Yin TL; Zhou LQ
J Transl Med; 2023 Oct; 21(1):746. PubMed ID: 37875936
[TBL] [Abstract][Full Text] [Related]
10. The Hope and Hype of CRISPR-Cas9 Genome Editing: A Review.
Musunuru K
JAMA Cardiol; 2017 Aug; 2(8):914-919. PubMed ID: 28614576
[TBL] [Abstract][Full Text] [Related]
11. Legality of Embryonic Gene Editing in Australia.
Taylor-Sands M; Gyngell C
J Law Med; 2018 Dec; 26(2):356-373. PubMed ID: 30574724
[TBL] [Abstract][Full Text] [Related]
12. Editing the human genome: where ART and science intersect.
Hershlag A; Bristow SL
J Assist Reprod Genet; 2018 Aug; 35(8):1367-1370. PubMed ID: 29882090
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations.
Memi F; Ntokou A; Papangeli I
Semin Perinatol; 2018 Dec; 42(8):487-500. PubMed ID: 30482590
[TBL] [Abstract][Full Text] [Related]
14. A Crispr Future for Gene-Editing Regulation: a Proposal for an Updated Biotechnology Regulatory System in an Era of Human Genomic Editing.
Tomlinson T
Fordham Law Rev; 2018 Oct; 87(1):437-83. PubMed ID: 30296034
[TBL] [Abstract][Full Text] [Related]
15. Carry on editing.
Greenfield A
Br Med Bull; 2018 Sep; 127(1):23-31. PubMed ID: 30202929
[TBL] [Abstract][Full Text] [Related]
16. Exploring the potential of genome editing CRISPR-Cas9 technology.
Singh V; Braddick D; Dhar PK
Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
[TBL] [Abstract][Full Text] [Related]
17. Precision editing in the human embryo.
Aschheim K
Nat Biotechnol; 2017 Sep; 35(9):832. PubMed ID: 28898212
[No Abstract] [Full Text] [Related]
18. [Back from Hong Kong or ethics at the time of a genetic increase of the human person].
Chneiweiss H
Med Sci (Paris); 2019 Mar; 35(3):263-265. PubMed ID: 30931912
[No Abstract] [Full Text] [Related]
19. Embryo editing takes another step to clinic.
Servick K
Science; 2017 Aug; 357(6350):436-437. PubMed ID: 28774906
[No Abstract] [Full Text] [Related]
20. Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing.
Kang X; He W; Huang Y; Yu Q; Chen Y; Gao X; Sun X; Fan Y
J Assist Reprod Genet; 2016 May; 33(5):581-588. PubMed ID: 27052831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
